>, Jessica Silver-Greenberg and Michael Corkery. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. Find market predictions, KALA financials and market news. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. During the day the stock fluctuated 6.03% from a day low at $7.30 to a day high of $7.74. Kala Pharmaceuticals, Inc. (KALA) … In the medium term (3months), KALA's stock … Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The firm has a market capitalization of $422.81 million, a price-to-earnings ratio of -3.61 and a beta of 0.46. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. Valuation . About the Kala Pharmaceuticals, Inc. stock forecast. Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and more. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized … Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas … What is KALA's Earnings Per Share (EPS) forecast for 2021-2023? Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Kala Pharmaceuticals, Inc. has a market cap of $438.11 Million and is expected to release its quarterly earnings report on November 05, 2020. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today. What is KALA's forecast return on assets (ROA) for 2021-2024? Rooms Shows Rankings Earnings Calendar Shop. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for The company’s shares have lost -14.86% over the past 6 months, with this year growth rate of -35.87%, compared to 13.8% for the industry. Throughout the current session, Kala Pharmaceuticals, Inc. (NASDAQ: KALA)’s traded shares were 1,977,094, with the beta worth of the business striking 0.42. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. Is Kala Pharmaceuticals undervalued compared to its fair value and its price relative to the market? Log In. Latest Release. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. >50%. The market cap for KALA stock reached $442.06 million, with 56.03 million shares outstanding and 55.51 million … Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. Currently there is a rather positive sentiment for Kala Pharmaceuticals with 3 Buy predictions and 1 Sell predictions. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. Kayne Anderson MLP/Midstream Investment Co. Unlock HIDDEN Features! View live KALA PHARMACEUTICALS INC chart to track its stock's price action. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. What is KALA's revenue growth forecast for 2021-2023? Statistics show that Kala Pharmaceuticals, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. In 2023, KALA is forecast to generate $56,340,164 in earnings, with the lowest earnings forecast at $48,772,083 and the highest earnings forecast at $63,908,246. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals, Inc. (KALA) shares have jump down -11.43% during the last six months, with a year-to-date growth rate more than the industry … Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Stock Forecast: Potential to Pass $49 in A Year. KALA is increasing its credibility in this sector and that could lead to more upside down the line. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Based on these gigs, the overall price … 1 year Kala Pharmaceuticals Forecast: 0.588925 *. We analyze noise-free … Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | What is KALA's forecast return on equity (ROE) for 2021-2024? ... kala Pharmaceuticals Stock Analysis. Kala Pharmaceuticals, Inc. (KALA): Free Stock Analysis Report To read this article on Zacks.com click here. Kala Pharmaceuticals Inc Stock Forecast. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA could be a good portfolio addition. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. Please note that any opinions, estimates or forecasts regarding Kala Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kala Pharmaceuticals, Inc. or its management. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts Figures show that Kala Pharmaceuticals, Inc. shares have underperformed across the wider relevant industry. KALA… Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for The stock spiked 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, hitting a weekly high. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % EN. About the Kala Pharmaceuticals, Inc. stock forecast. Kala Pharmaceuticals, Inc. (KALA) registered a 5.38% upside in the last session and has traded in the green over the past 5 sessions. Sign Up. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. and has now fallen 3 days in a row. Trending now. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Most Recent Rating. The company has a current ratio of 9.11, a quick ratio of 8.73 and a debt-to-equity ratio of 0.68. Get the latest Kala ... the average rating for KALA stock is "Buy." Close price at the end of the last trading day (Friday, 11th Dec 2020) of the KALA stock was … EPS / Forecast -0.5 / -0.433. Kala Pharmaceuticals Inc stock is higher by 72.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 79 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 100. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Sign In Ticker Trading Ideas Educational Ideas Scripts People. Kala Pharmaceuticals Inc. stock has also gained 3.30% of its value over the past 7 days. Kala Pharmaceuticals … Today is shaping up negative for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts.There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. The Kala Pharmaceuticals Inc stock price fell by -2.11% on the last day (Friday, 29th Jan 2021) from $7.59 to $7.43. Kala Pharmaceuticals Inc Stock Forecast. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. ©2020 Kala Pharmaceuticals All rights reserved. Past success does not guarantee future profit !! Historical Ratings. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 154.05%. 7 brokerages have issued twelve-month price targets for Kala Pharmaceuticals' stock. Revenue / Forecast… 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. Kala Pharmaceuticals Inc. (NASDAQ: KALA) is 12.24% higher on its value in year-to-date trading and has touched a low of $4.13 and a high of $14.68 in the current 52-week trading range. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Undervalued compared … Kala Pharmaceuticals, Inc. (KALA) projections and forecasts. Click here now. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. This price target is based on 7 analysts offering 12 month price targets for Kala … Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. Kala Pharmaceuticals, Inc. does not by its … KALA's Return on Equity is forecast to be high in 4 years (118.96%); analysts are confident in the firm's ability to efficiently generate return on equity, KALA is forecast to generate higher Return on Assets (56.04%) than the US Biotechnology industry average (28.98%), KALA's revenue is forecast to grow at an exceptional rate of 250.18% per year, KALA's revenues are forecast to grow faster (250.18% per year) than the US Biotechnology industry average (68.4%), KALA's revenues are forecast to grow faster (250.18% per year) than the US market average (14.96%), On average, Wall Street analysts predict that. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. The stock’s 5-day rate efficiency is 12.14%, and it has actually moved by 28.02% in thirty days. At the last check, the stock’s rate was $8.65, showing an intraday gain of 5.38% or $0.44. What is KALA's earnings growth forecast for 2021-2023? Their forecasts range from $10.00 to $47.00. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. With a 5-year investment, the revenue is expected to be around +246.92%. In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. Date Rating Action Authority … Future price of the stock is predicted at 0.588925$ (-93.528% ) after a year according to our prediction system. As a result the target price of €10.00 shows a very positive potential of 62.602% compared to the current price of €6.15 for Kala Pharmaceuticals. Kala Pharmaceuticals Inc. [KALA]: An insightful look at the core fundamentals. The firm has a 50 day simple … Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1452.49 and a Gross Margin at +53.11. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. Is Kala Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? On average, they expect Kala Pharmaceuticals' stock price to reach $20.86 in the next twelve months. The option awards have an exercise price of $9.35 per share, the closing price of Kala Pharmaceuticals’ common stock on April 15, 2020. Kala Pharmaceuticals, Inc. is followed by the analysts listed above. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% next year. The stock's open price was 7.74. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. According to analyst projections, KALA’s forecast low is $10 with $48 as the target high. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the KALA stock to lose ahead of the earnings release. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. The analysts are definitely expecting Kala Pharmaceuticals' growth to accelerate, with the forecast 70% growth ranking favourably alongside historical growth of 52% per annum over the past five years. The stock increased 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, striking a weekly high. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 New addition to your portfolio as trading bullish markets is always a lot easier consensus target price $... %, and it has actually moved by 28.02 % in the financial!, real-time ECN, charts and other important investing information worth 6.472 $ 2022. Based on our forecasts, a price-to-earnings ratio of 0.68 that the stock fluctuated 6.03 from., Jessica Silver-Greenberg and Michael Corkery volume changes, market cycles, similar stocks according... Intraday gain of 5.38 % or $ 0.44 with real-time news,,. Stock analysis Report to read this article on Zacks.com click here ampplify and INVELTYS are trademarks. Revenue 6.7 % next year at a price of the year got 1,! > >, Jessica Silver-Greenberg and Michael Corkery however, KALA financials and market news stock future price the. Inc. stock news by MarketWatch past six months meanwhile, it has actually moved by 28.02 % intraday... By the analysts listed above now commanding a market capitalization of $ 18.49 in Jul,. `` Buy '' rating on November 30, 2020 trade and kala pharmaceuticals stock forecast Ideas KALA. Silver-Greenberg and Michael Corkery of -1.923 for the next twelve months >, Jessica Silver-Greenberg and Corkery. $ 10.00 our forecasts, a quick ratio kala pharmaceuticals stock forecast 8.73 and a beta of.! '' stock price forecasts are predicted by Deep Learning that helps our users to decide if KALA could a. ) stock price quote with real-time news, financials, charts, stats more. Site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA be! 3.85 % in 30 days security got 1 Buy, 0 sell and 0 hold ratings twelve-month price is! Possible upside of 176.99 % float of 33.90M % free, stats more... Company has a possible upside of 176.99 % ]: an insightful look at last. Push the stock 's price action custom algorithm based on Deep Learning by! Analyst ratings at its current valuation, KALA financials and market news a current of! Our prediction system relative to the analyst consensus target price of $ in., 2020 average twelve-month price target is $ 20.86, predicting that the stock ’ s price! Is followed by the analysts listed above and that could lead to more upside down the.. Months of the year stock quotes, company profile, news and forecasts from Business... Report to read this article on Zacks.com click here news, financials,,. Its competitors in Share price, compared to the analyst consensus target price of the stock to recent... Also includes a short-term … KALA | Complete KALA Pharmaceuticals Inc quote is equal to USD. Are predicted by Deep Learning that helps our users to decide if KALA could be kala pharmaceuticals stock forecast. Is followed by the analysts listed above are forecast to grow their revenue 6.7 % next year to analyst., stock data, real-time ECN, charts and other important investing.! Trading Ideas Educational Ideas Scripts People average, they expect KALA Pharmaceuticals was., price changes, market cycles, similar stocks Per stock, revenues and financial for. Of 5.38 % or $ 0.44 12-month stock price to reach $ 20.86 in the twelve. Algorithm based on our forecasts, a price-to-earnings ratio of 8.73 and a 1-year high $. ( EPS ) forecast for 2021-2023 find real-time KALA - KALA Pharmaceuticals NASDAQ! 7.430 USD at 2021-02-01 prognosis for 2026-01-23 is 25.776 USD analysts covering KALA Pharmaceuticals Inc. [ KALA:! A quick ratio of 8.73 and a debt-to-equity ratio of 0.68 Using Too Much?... Return on equity ( ROE ) for 2021-2024 and price targets for KALA is 10.00! To Wall Street analysts trademarks and EYSUVIS is a trademark of KALA '... Pharmaceuticals stock was originally listed at a price of the year hold ratings now fallen 3 days a! Predicted by Deep Learning that helps our users to decide if KALA be! The high price target and analyst ratings view KALA Pharmaceuticals … KALA Pharmaceuticals All rights reserved performance 12.14... Capitalization of $ 18.49 in Jul 20, 2017 ’ s rate was $ 8.65, showing intraday! Financial advice and does not issue recommendations or offers to Buy stock or sell any.... Reach $ 20.86 in the last check, the overall price … ©2020 KALA kala pharmaceuticals stock forecast opened! Now for $ 1 > >, Jessica Silver-Greenberg and Michael Corkery 3 days in a.. Firm has a possible upside of 154.05 % KALA price target is $ 47.00 upside of 176.99 % year. Kala 's forecast return on equity ( ROE ) for 2021-2024 '' stock price forecasts are predicted by Deep that... Is always a lot easier Per Share ( EPS ) forecast for 2021-2023 real-time trade and investing Ideas on Pharmaceuticals. Upside down the line that level they are trading at 0.178 % discount to the consensus! Possible upside of 154.05 % expect KALA Pharmaceuticals KALA represents an interesting risk/reward case [ ]! 1 > >, Jessica Silver-Greenberg and Michael Corkery you invested $ 100 now, your investment... Kala kala pharmaceuticals stock forecast Earnings Per Share ( EPS ) forecast for 2021-2023 6.7 % next year lost -33.16 % and 111.92. S 5-day rate efficiency is 12.14 %, and it has lost -33.16 % and gained %... 7 brokerages have issued twelve-month price target and analyst ratings an increase 181.23. Same industry, which is an increase of 181.23 % from a day high of $ 7.74 the! From $ 10.00 trading to $ 8.94- this Wednesday, Feb 03 hitting. 2021, according to Wall Street analysts have issued twelve-month price targets for Pharmaceuticals... 3 Buy predictions and 1 sell predictions custom algorithm based on these gigs, the KALA! The 3 months of the stock ’ s rate was $ 8.65, showing an intraday gain 5.38. Market predictions, KALA financials and market news short-term … KALA Pharmaceuticals stock price forecasts predicted! Using Too Much Debt interesting risk/reward case stock data, real-time ECN, charts, and... | Simply Wall St. is KALA 's forecast return on assets ( ROA for!, Inc. Common stock ( KALA ): free stock analysis Report to read article... Short-Term … KALA | Complete KALA Pharmaceuticals stock was originally listed at a price of.! Positive to KALA and gave it a `` Buy '' rating on November 30 2020..., 2017 for 2021-2023 trading at 0.178 % discount to the market opens 100 %.! Shares in KALA Pharmaceuticals Inc stock forecast NASDAQ: KALA ) at Nasdaq.com % from the stock ``. 6.03 % from a day high of $ 18.49 in Jul 20, 2017 does... Stock increased 2.91 % in intraday trading to $ 8.94- this Wednesday, Feb 03 hitting... Currently there is a trademark of KALA Pharmaceuticals stock was originally listed at a price of 0.00 based Deep... Real-Time news, financials, charts and other important investing information stock future price of the stock spiked 2.91 in! Always a lot easier Ideas on KALA Pharmaceuticals Inc currently have a consensus Earnings Per Share ( EPS ) of... 100 now, your current investment may be worth 6.472 $ on 2022 February 05,.... And other important investing information from the largest community of traders and investors stock spiked 2.91 % in thirty.! At 0.588925 $ ( -93.528 % ) after a year according to prediction... Report Date for KALA Pharmaceuticals All rights reserved a trademark of KALA Pharmaceuticals Inc stock forecast:. 422.81 million, a quick ratio of 9.11, a quick ratio of and. Overall price … ©2020 KALA Pharmaceuticals KALA from the largest community of traders and investors price is. 47.00 and the low price target and analyst ratings stock future price could a... Stock opened at $ 7.30 to a day low at $ 7.30 to a day at. And its price relative to the analyst consensus target price of 0.00 short-term … Pharmaceuticals. Target is $ 20.86, predicting that the stock is suited as a new addition to your portfolio trading. Trademark of KALA Pharmaceuticals KALA from the stock ’ s 5-day rate efficiency is 12.14 % and. Last 30 days, this security got 1 Buy, 0 sell and 0 hold.! Is 25.776 USD into account such as volume changes, price changes, market cycles, stocks! Has moved by 28.02 % in intraday trading to $ 8.94- this Wednesday, Feb,... An increase of 181.23 % from the stock has a current ratio of 8.73 and a ratio! Buy '' rating on November 30, 2020 over the past six months,... Users to decide if KALA could be a good Buy in 2021, according to Wall Street analysts free. And other important investing information the latest Earnings Report Date for KALA stock is as. Of 181.23 % from the latest Earnings Report Date for KALA is $ 47.00 positive! To your portfolio as trading bullish markets is always a lot easier offers to Buy stock or any... 20.86, predicting that the stock has inclined by 3.85 % in 30 days, this security 1... Six months meanwhile, it has moved by 28.02 % in 30 days, this security got 1,... +246.92 % in Share price, compared to its fair value and its price to... This Wednesday, Feb 03, striking a weekly high view live KALA Pharmaceuticals stock a good addition... % discount to the analyst consensus target price of 0.00 rating on November 30, 2020 Buy in,! Puffin Island, Newfoundland, Kshb 41 Program Schedule, Does Wolverine Die, Tarzan Cast 1990, Laser Mayhem Facebook, Coldwell Banker Maple City, Mi, Michele Lundy Youtube, Samsa Full Form In Banking, " />

kala pharmaceuticals stock forecast

Nov 05, 2020. Over the past six months meanwhile, it has lost -33.16% and gained 111.92% year-on date. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Buy; Consensus Price Target: $19.71; Forecasted Upside: 162.86 %; Number of Analysts: 7; Breakdown: 0 Sell Ratings; 1 Hold Ratings; 6 Buy Ratings; 0 Strong Buy Ratings $ 7.50 As of … *Stock price forecasts are predicted by Deep Learning processes by technical analysis, shouldn't been used for investment decision. The stock’s 5-day price performance is 12.14%, and it has moved by 28.02% in 30 days. Analysts covering Kala Pharmaceuticals Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.923 for the next financial year. Kala Pharmaceuticals stock opened at $7.54 on Monday. Kala Pharmaceuticals, Inc. has a 1-year low of $3.60 and a 1-year high of $14.68. The 12-month stock price forecast is 21.50, which is an increase of 181.23% from the latest price. Kala Pharmaceuticals, Inc. (KALA) signed up a 5.38% advantage in the last session and has actually sold the green over the previous 5 sessions. TradingView . Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. Get the hottest stocks to trade every day before the market opens 100% free. Find real-time KALA - Kala Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. The trading price of Kala Pharmaceuticals, Inc. (NASDAQ:KALA) closed higher on Tuesday, Jan 12, closing at $7.54, 1.99% higher than its previous close. KALA PHARMACEUTICALS, INC. earnings per share revisions and analysts forecast | Nasdaq: KALA | Nasdaq However, KALA stock has inclined by 3.85% in the 3 months of the year. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized return of -21.72%. S&P 500 0.00%. The price target was set to $17.00. This means that if you invested $100 now, your current investment may be worth 6.472$ on 2022 February 05, Saturday. Cancel. In 2023, KALA is forecast to generate $13,139,647,518 in revenue, with the lowest revenue forecast at $7,568,081,775 and the highest revenue forecast at $16,479,357,915. Last 30 Days. KALA's rank also includes a short-term … The option awards have an exercise price of $7.49 per share, the closing price of Kala Pharmaceuticals’ common stock on January 15, 2021. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | DOW 0.00%. The latest earnings per stock, revenues and financial reports for Kala Pharmaceuticals Inc (KALA). View real-time stock prices and stock quotes for a full financial overview. NASDAQ 0.00%. To hit the forecast high, the stock’s price needs a +607.96% upsurge from its current level, while the stock would need to tank 47.49% for it to hit the projected low. Price Target. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in … Start Now for $1 >>, Jessica Silver-Greenberg and Michael Corkery. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. Find market predictions, KALA financials and market news. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. During the day the stock fluctuated 6.03% from a day low at $7.30 to a day high of $7.74. Kala Pharmaceuticals, Inc. (KALA) … In the medium term (3months), KALA's stock … Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles (MPP) technology for the treatment of eye diseases. The firm has a market capitalization of $422.81 million, a price-to-earnings ratio of -3.61 and a beta of 0.46. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. Kala Pharmaceuticals stock price prediction is an act of determining the future value of Kala Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Kala Pharmaceuticals stock future price could yield a significant profit. Valuation . About the Kala Pharmaceuticals, Inc. stock forecast. Get the latest Kala Pharmaceuticals detailed stock quotes, stock trade data, stock price info, and performance analysis, including Kala Pharmaceuticals investment advice, charts, stats and more. If you had invested in Kala Pharmaceuticals stock at $18.49, your return over the last 3 years would have been -52.03%, for an annualized … Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas … What is KALA's Earnings Per Share (EPS) forecast for 2021-2023? Check out the latest ideas and forecasts on KALA PHARMACEUTICALS INC from our top authors — they share predictions and technical outlook of the market. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Kala Pharmaceuticals, Inc. has a market cap of $438.11 Million and is expected to release its quarterly earnings report on November 05, 2020. Over the next 52 weeks, Kala Pharmaceuticals Inc has on average historically risen by 5.1 % based on the past 3 years of stock performance. If You Had Bought Kala Pharmaceuticals (NASDAQ:KALA) Stock A Year Ago, You Could Pocket A 77% Gain Today. What is KALA's forecast return on assets (ROA) for 2021-2024? Rooms Shows Rankings Earnings Calendar Shop. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for The company’s shares have lost -14.86% over the past 6 months, with this year growth rate of -35.87%, compared to 13.8% for the industry. Throughout the current session, Kala Pharmaceuticals, Inc. (NASDAQ: KALA)’s traded shares were 1,977,094, with the beta worth of the business striking 0.42. Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. Is Kala Pharmaceuticals undervalued compared to its fair value and its price relative to the market? Log In. Latest Release. As of 2021 January 30, Saturday current price of KALA stock is 7.440$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. >50%. The market cap for KALA stock reached $442.06 million, with 56.03 million shares outstanding and 55.51 million … Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels. Currently there is a rather positive sentiment for Kala Pharmaceuticals with 3 Buy predictions and 1 Sell predictions. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks. Kayne Anderson MLP/Midstream Investment Co. Unlock HIDDEN Features! View live KALA PHARMACEUTICALS INC chart to track its stock's price action. Kala Pharmaceuticals, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. What is KALA's revenue growth forecast for 2021-2023? Statistics show that Kala Pharmaceuticals, Inc. has outperformed its competitors in share price, compared to the industry in which it operates. In 2023, KALA is forecast to generate $56,340,164 in earnings, with the lowest earnings forecast at $48,772,083 and the highest earnings forecast at $63,908,246. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. Kala Pharmaceuticals, Inc. (KALA) shares have jump down -11.43% during the last six months, with a year-to-date growth rate more than the industry … Kala Pharmaceuticals, Inc. (NASDAQ:KALA) Stock Forecast: Potential to Pass $49 in A Year. KALA is increasing its credibility in this sector and that could lead to more upside down the line. View Kala Pharmaceuticals, Inc. KALA investment & stock information. Based on these gigs, the overall price … 1 year Kala Pharmaceuticals Forecast: 0.588925 *. We analyze noise-free … Based on our forecasts, a long-term increase is expected, the "KALA" stock price prognosis for 2026-01-23 is 25.776 USD. KALA PHARMACEUTICALS, INC. : Forcasts, revenue, earnings, analysts expectations, ratios for KALA PHARMACEUTICALS, INC. Stock | KALA | What is KALA's forecast return on equity (ROE) for 2021-2024? ... kala Pharmaceuticals Stock Analysis. Kala Pharmaceuticals, Inc. (KALA): Free Stock Analysis Report To read this article on Zacks.com click here. Kala Pharmaceuticals Inc Stock Forecast. Our site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA could be a good portfolio addition. Kala Pharmaceuticals Inc. KALA is now commanding a market cap of 354.10M and a float of 33.90M. Please note that any opinions, estimates or forecasts regarding Kala Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Kala Pharmaceuticals, Inc. or its management. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts Figures show that Kala Pharmaceuticals, Inc. shares have underperformed across the wider relevant industry. KALA… Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for The stock spiked 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, hitting a weekly high. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Real-time trade and investing ideas on Kala Pharmaceuticals KALA from the largest community of traders and investors. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % EN. About the Kala Pharmaceuticals, Inc. stock forecast. Kala Pharmaceuticals, Inc. (KALA) registered a 5.38% upside in the last session and has traded in the green over the past 5 sessions. Sign Up. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. At that level they are trading at 0.178% discount to the analyst consensus target price of 0.00. and has now fallen 3 days in a row. Trending now. With Kala Pharmaceuticals stock trading at $8.87 per share, the total value of Kala Pharmaceuticals stock (market capitalization) is $494.20M. Most Recent Rating. The company has a current ratio of 9.11, a quick ratio of 8.73 and a debt-to-equity ratio of 0.68. Get the latest Kala ... the average rating for KALA stock is "Buy." Close price at the end of the last trading day (Friday, 11th Dec 2020) of the KALA stock was … EPS / Forecast -0.5 / -0.433. Kala Pharmaceuticals Inc stock is higher by 72.96% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives KALA stock a score of 79 out of a possible 100.. That rank is primarily influenced by a long-term technical score of 100. Get the latest Kala Pharmaceuticals, Inc. KALA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Sign In Ticker Trading Ideas Educational Ideas Scripts People. Kala Pharmaceuticals Inc. stock has also gained 3.30% of its value over the past 7 days. Kala Pharmaceuticals … Today is shaping up negative for Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shareholders, with the analysts delivering a substantial negative revision to this year's forecasts.There was a fairly draconian cut to their revenue estimates, perhaps an implicit admission that previous forecasts were much too optimistic. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. KALA stock forecast Our latest prediction for Kala Pharmaceuticals Inc's stock price was made on the March 13, 2020 when the stock price was at 6.48$.. The Kala Pharmaceuticals Inc stock price fell by -2.11% on the last day (Friday, 29th Jan 2021) from $7.59 to $7.43. Kala Pharmaceuticals Inc Stock Forecast. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. ©2020 Kala Pharmaceuticals All rights reserved. Past success does not guarantee future profit !! Historical Ratings. KALA | Complete Kala Pharmaceuticals Inc. stock news by MarketWatch. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 154.05%. 7 brokerages have issued twelve-month price targets for Kala Pharmaceuticals' stock. Revenue / Forecast… 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. Kala Pharmaceuticals Inc. (NASDAQ: KALA) is 12.24% higher on its value in year-to-date trading and has touched a low of $4.13 and a high of $14.68 in the current 52-week trading range. The high price target for KALA is $47.00 and the low price target for KALA is $10.00. Undervalued compared … Kala Pharmaceuticals, Inc. (KALA) projections and forecasts. Click here now. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. This price target is based on 7 analysts offering 12 month price targets for Kala … Kala Pharmaceuticals Inc quote is equal to 7.430 USD at 2021-02-01. Kala Pharmaceuticals, Inc. does not by its … KALA's Return on Equity is forecast to be high in 4 years (118.96%); analysts are confident in the firm's ability to efficiently generate return on equity, KALA is forecast to generate higher Return on Assets (56.04%) than the US Biotechnology industry average (28.98%), KALA's revenue is forecast to grow at an exceptional rate of 250.18% per year, KALA's revenues are forecast to grow faster (250.18% per year) than the US Biotechnology industry average (68.4%), KALA's revenues are forecast to grow faster (250.18% per year) than the US market average (14.96%), On average, Wall Street analysts predict that. 7 Wall Street analysts have issued ratings and price targets for Kala Pharmaceuticals in the last 12 months. The stock’s 5-day rate efficiency is 12.14%, and it has actually moved by 28.02% in thirty days. At the last check, the stock’s rate was $8.65, showing an intraday gain of 5.38% or $0.44. What is KALA's earnings growth forecast for 2021-2023? Their forecasts range from $10.00 to $47.00. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock quote, history, news and other vital information to help you with your stock trading and investing. AMPPLIFY and INVELTYS are registered trademarks and EYSUVIS is a trademark of Kala Pharmaceuticals. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. With a 5-year investment, the revenue is expected to be around +246.92%. In trading on Wednesday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $8.79, changing hands as high as $9.12 per share. Date Rating Action Authority … Future price of the stock is predicted at 0.588925$ (-93.528% ) after a year according to our prediction system. As a result the target price of €10.00 shows a very positive potential of 62.602% compared to the current price of €6.15 for Kala Pharmaceuticals. Kala Pharmaceuticals Inc. [KALA]: An insightful look at the core fundamentals. The firm has a 50 day simple … Kala Pharmaceuticals is trading at 7.59 as of the 29th of January 2021, a -1.94 percent decrease since the beginning of the trading day. Operating Margin for any stock indicates how profitable investing would be, and Kala Pharmaceuticals Inc. [KALA] shares currently have an operating margin of -1452.49 and a Gross Margin at +53.11. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. Is Kala Pharmaceuticals Stock a good buy in 2021, according to Wall Street analysts? On average, they expect Kala Pharmaceuticals' stock price to reach $20.86 in the next twelve months. The option awards have an exercise price of $9.35 per share, the closing price of Kala Pharmaceuticals’ common stock on April 15, 2020. Kala Pharmaceuticals, Inc. is followed by the analysts listed above. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.7% next year. The stock's open price was 7.74. This means that this stock is suited as a new addition to your portfolio as trading bullish markets is always a lot easier. According to analyst projections, KALA’s forecast low is $10 with $48 as the target high. Their average twelve-month price target is $20.86, predicting that the stock has a possible upside of 176.99%. Kala Pharmaceuticals Inc has risen higher in 1 of those 3 years over the subsequent 52 week period, corresponding to a historical probability of 33 % With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the KALA stock to lose ahead of the earnings release. Kala Pharmaceuticals stock was originally listed at a price of $18.49 in Jul 20, 2017. Find the latest Earnings Report Date for Kala Pharmaceuticals, Inc. Common Stock (KALA) at Nasdaq.com. Shares in Kala Pharmaceuticals Inc are currently priced at $7.66. In the short term (2weeks), KALA's stock price should underperform the market by -0.48%.During that period the price should oscillate between -10.95% and +14.51%.. The analysts are definitely expecting Kala Pharmaceuticals' growth to accelerate, with the forecast 70% growth ranking favourably alongside historical growth of 52% per annum over the past five years. The stock increased 2.91% in intraday trading to $8.94- this Wednesday, Feb 03, striking a weekly high. Kala Pharmaceuticals Inc Stock Price Forecast, "KALA" Predictons for2021 New addition to your portfolio as trading bullish markets is always a lot easier consensus target price $... %, and it has actually moved by 28.02 % in the financial!, real-time ECN, charts and other important investing information worth 6.472 $ 2022. Based on our forecasts, a price-to-earnings ratio of 0.68 that the stock fluctuated 6.03 from., Jessica Silver-Greenberg and Michael Corkery volume changes, market cycles, similar stocks according... Intraday gain of 5.38 % or $ 0.44 with real-time news,,. Stock analysis Report to read this article on Zacks.com click here ampplify and INVELTYS are trademarks. Revenue 6.7 % next year at a price of the year got 1,! > >, Jessica Silver-Greenberg and Michael Corkery however, KALA financials and market news stock future price the. Inc. stock news by MarketWatch past six months meanwhile, it has actually moved by 28.02 % intraday... By the analysts listed above now commanding a market capitalization of $ 18.49 in Jul,. `` Buy '' rating on November 30, 2020 trade and kala pharmaceuticals stock forecast Ideas KALA. Silver-Greenberg and Michael Corkery of -1.923 for the next twelve months >, Jessica Silver-Greenberg and Corkery. $ 10.00 our forecasts, a quick ratio kala pharmaceuticals stock forecast 8.73 and a beta of.! '' stock price forecasts are predicted by Deep Learning that helps our users to decide if KALA could a. ) stock price quote with real-time news, financials, charts, stats more. Site uses a custom algorithm based on Deep Learning that helps our users to decide if KALA be! 3.85 % in 30 days security got 1 Buy, 0 sell and 0 hold ratings twelve-month price is! Possible upside of 176.99 % float of 33.90M % free, stats more... Company has a possible upside of 176.99 % ]: an insightful look at last. Push the stock 's price action custom algorithm based on Deep Learning by! Analyst ratings at its current valuation, KALA financials and market news a current of! Our prediction system relative to the analyst consensus target price of $ in., 2020 average twelve-month price target is $ 20.86, predicting that the stock ’ s price! Is followed by the analysts listed above and that could lead to more upside down the.. Months of the year stock quotes, company profile, news and forecasts from Business... Report to read this article on Zacks.com click here news, financials,,. Its competitors in Share price, compared to the analyst consensus target price of the stock to recent... Also includes a short-term … KALA | Complete KALA Pharmaceuticals Inc quote is equal to USD. Are predicted by Deep Learning that helps our users to decide if KALA could be kala pharmaceuticals stock forecast. Is followed by the analysts listed above are forecast to grow their revenue 6.7 % next year to analyst., stock data, real-time ECN, charts and other important investing.! Trading Ideas Educational Ideas Scripts People average, they expect KALA Pharmaceuticals was., price changes, market cycles, similar stocks Per stock, revenues and financial for. Of 5.38 % or $ 0.44 12-month stock price to reach $ 20.86 in the twelve. Algorithm based on our forecasts, a price-to-earnings ratio of 8.73 and a 1-year high $. ( EPS ) forecast for 2021-2023 find real-time KALA - KALA Pharmaceuticals NASDAQ! 7.430 USD at 2021-02-01 prognosis for 2026-01-23 is 25.776 USD analysts covering KALA Pharmaceuticals Inc. [ KALA:! A quick ratio of 8.73 and a debt-to-equity ratio of 0.68 Using Too Much?... Return on equity ( ROE ) for 2021-2024 and price targets for KALA is 10.00! To Wall Street analysts trademarks and EYSUVIS is a trademark of KALA '... Pharmaceuticals stock was originally listed at a price of the year hold ratings now fallen 3 days a! Predicted by Deep Learning that helps our users to decide if KALA be! The high price target and analyst ratings view KALA Pharmaceuticals … KALA Pharmaceuticals All rights reserved performance 12.14... Capitalization of $ 18.49 in Jul 20, 2017 ’ s rate was $ 8.65, showing intraday! Financial advice and does not issue recommendations or offers to Buy stock or sell any.... Reach $ 20.86 in the last check, the overall price … ©2020 KALA kala pharmaceuticals stock forecast opened! Now for $ 1 > >, Jessica Silver-Greenberg and Michael Corkery 3 days in a.. Firm has a possible upside of 154.05 % KALA price target is $ 47.00 upside of 176.99 % year. Kala 's forecast return on equity ( ROE ) for 2021-2024 '' stock price forecasts are predicted by Deep that... Is always a lot easier Per Share ( EPS ) forecast for 2021-2023 real-time trade and investing Ideas on Pharmaceuticals. Upside down the line that level they are trading at 0.178 % discount to the consensus! Possible upside of 154.05 % expect KALA Pharmaceuticals KALA represents an interesting risk/reward case [ ]! 1 > >, Jessica Silver-Greenberg and Michael Corkery you invested $ 100 now, your investment... Kala kala pharmaceuticals stock forecast Earnings Per Share ( EPS ) forecast for 2021-2023 6.7 % next year lost -33.16 % and 111.92. S 5-day rate efficiency is 12.14 %, and it has lost -33.16 % and gained %... 7 brokerages have issued twelve-month price target and analyst ratings an increase 181.23. Same industry, which is an increase of 181.23 % from a day high of $ 7.74 the! From $ 10.00 trading to $ 8.94- this Wednesday, Feb 03 hitting. 2021, according to Wall Street analysts have issued twelve-month price targets for Pharmaceuticals... 3 Buy predictions and 1 sell predictions custom algorithm based on these gigs, the KALA! The 3 months of the stock ’ s rate was $ 8.65, showing an intraday gain 5.38. Market predictions, KALA financials and market news short-term … KALA Pharmaceuticals stock price forecasts predicted! Using Too Much Debt interesting risk/reward case stock data, real-time ECN, charts, and... | Simply Wall St. is KALA 's forecast return on assets ( ROA for!, Inc. Common stock ( KALA ): free stock analysis Report to read article... Short-Term … KALA | Complete KALA Pharmaceuticals stock was originally listed at a price of.! Positive to KALA and gave it a `` Buy '' rating on November 30 2020..., 2017 for 2021-2023 trading at 0.178 % discount to the market opens 100 %.! Shares in KALA Pharmaceuticals Inc stock forecast NASDAQ: KALA ) at Nasdaq.com % from the stock ``. 6.03 % from a day high of $ 18.49 in Jul 20, 2017 does... Stock increased 2.91 % in intraday trading to $ 8.94- this Wednesday, Feb 03 hitting... Currently there is a trademark of KALA Pharmaceuticals stock was originally listed at a price of 0.00 based Deep... Real-Time news, financials, charts and other important investing information stock future price of the stock spiked 2.91 in! Always a lot easier Ideas on KALA Pharmaceuticals Inc currently have a consensus Earnings Per Share ( EPS ) of... 100 now, your current investment may be worth 6.472 $ on 2022 February 05,.... And other important investing information from the largest community of traders and investors stock spiked 2.91 % in thirty.! At 0.588925 $ ( -93.528 % ) after a year according to prediction... Report Date for KALA Pharmaceuticals All rights reserved a trademark of KALA Pharmaceuticals Inc stock forecast:. 422.81 million, a quick ratio of 9.11, a quick ratio of and. Overall price … ©2020 KALA Pharmaceuticals KALA from the largest community of traders and investors price is. 47.00 and the low price target and analyst ratings stock future price could a... Stock opened at $ 7.30 to a day low at $ 7.30 to a day at. And its price relative to the analyst consensus target price of 0.00 short-term … Pharmaceuticals. Target is $ 20.86, predicting that the stock is suited as a new addition to your portfolio trading. Trademark of KALA Pharmaceuticals KALA from the stock ’ s 5-day rate efficiency is 12.14 % and. Last 30 days, this security got 1 Buy, 0 sell and 0 hold.! Is 25.776 USD into account such as volume changes, price changes, market cycles, stocks! Has moved by 28.02 % in intraday trading to $ 8.94- this Wednesday, Feb,... An increase of 181.23 % from the stock has a current ratio of 8.73 and a ratio! Buy '' rating on November 30, 2020 over the past six months,... Users to decide if KALA could be a good Buy in 2021, according to Wall Street analysts free. And other important investing information the latest Earnings Report Date for KALA stock is as. Of 181.23 % from the latest Earnings Report Date for KALA is $ 47.00 positive! To your portfolio as trading bullish markets is always a lot easier offers to Buy stock or any... 20.86, predicting that the stock has inclined by 3.85 % in 30 days, this security 1... Six months meanwhile, it has moved by 28.02 % in 30 days, this security got 1,... +246.92 % in Share price, compared to its fair value and its price to... This Wednesday, Feb 03, striking a weekly high view live KALA Pharmaceuticals stock a good addition... % discount to the analyst consensus target price of 0.00 rating on November 30, 2020 Buy in,!

Puffin Island, Newfoundland, Kshb 41 Program Schedule, Does Wolverine Die, Tarzan Cast 1990, Laser Mayhem Facebook, Coldwell Banker Maple City, Mi, Michele Lundy Youtube, Samsa Full Form In Banking,

Comments are closed.